Meidong Xu[Author] - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2005	1
2006	5
2007	4
2008	3
2009	1
2010	1
2011	10
2012	20
2013	13
2014	13
2015	12
2016	14
2017	16
2018	15
2019	21
2020	11
2021	10
2022	17
2023	17
2024	10

1

Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.

Fang K, Sun M, Leng Z, Chu Y, Zhao Z, Li Z, Zhang Y, Xu A, Zhang Z, Zhang L, Chen T, Xu M. Fang K, et al. Among authors: xu m. J Exp Clin Cancer Res. 2023 Mar 28;42(1):73. doi: 10.1186/s13046-023-02623-2. J Exp Clin Cancer Res. 2023. PMID: 36978187 Free PMC article.

2

IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia.

Zheng K, Sha N, Hou G, Leng Z, Zhao Q, Zhang L, He L, Xu M, Jiang Y, Chen T. Zheng K, et al. Among authors: xu m. Nat Commun. 2023 Sep 30;14(1):6117. doi: 10.1038/s41467-023-41658-z. Nat Commun. 2023. PMID: 37777542 Free PMC article.

3

TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM.

Sun M, Li Z, Wang X, Zhao M, Chu Y, Zhang Z, Fang K, Zhao Z, Feng A, Leng Z, Shi J, Zhang L, Chen T, Xu M. Sun M, et al. Among authors: xu m. Adv Sci (Weinh). 2023 Oct;10(29):e2300864. doi: 10.1002/advs.202300864. Epub 2023 Sep 13. Adv Sci (Weinh). 2023. PMID: 37705061 Free PMC article.

4

Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials.

Wang Z, Du H, Zhao Y, Ren Y, Ma C, Chen H, Li M, Tian J, Xue C, Long G, Xu M, Jiang Y. Wang Z, et al. Among authors: xu m. Front Endocrinol (Lausanne). 2023 Mar 29;14:1111430. doi: 10.3389/fendo.2023.1111430. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37065735 Free PMC article.

5

MALT Lymphoma of the Esophagus.

Lian J, Xu A, Xu M. Lian J, et al. Among authors: xu m. Clin Gastroenterol Hepatol. 2024 Feb 27:S1542-3565(24)00220-9. doi: 10.1016/j.cgh.2024.02.016. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38423345 No abstract available.

6

No-touch endoscopic full-thickness resection technique for gastric gastrointestinal stromal tumors.

Chen T, Zhang YW, Lian JJ, Zhang HB, Xu AP, Li F, Yan XH, Duan BS, Zhao ZY, Chu Y, Shen L, Cao J, Zhang L, Zheng L, Chu SG, Xu MD. Chen T, et al. Endoscopy. 2023 Jun;55(6):557-562. doi: 10.1055/a-2013-1902. Epub 2023 Feb 9. Endoscopy. 2023. PMID: 36758584

7

Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study.

Jiang X, Pan J, Xu Q, Song YH, Sun HH, Peng C, Qi XL, Qian YY, Zou WB, Yang Y, Jin SQ, Duan BS, Wu S, Chu Y, Xiao DH, Hu LJ, Cao JZ, Dai JF, Liu X, Xia T, Zhou W, Chen T, Zhou CH, Wu W, Liu SJ, Yang ZY, Wang F, Zhang L, Li CZ, Xu H, Wang JX, Wei B, Lin Y, Deng X, Qu LH, Shen YQ, Wang H, Huang YF, Bao HB, Zhang S, Li L, Shi YH, Wang XY, Zou DW, Wan XJ, Xu MD, Mao H, He CH, Li Z, Zuo XL, He SX, Xie XP, Liu J, Yang CQ, Spada C, Li ZS, Liao Z. Jiang X, et al. BMJ. 2024 Mar 5;384:e078581. doi: 10.1136/bmj-2023-078581. BMJ. 2024. PMID: 38443074 Free PMC article. Clinical Trial.

8

Current Status of Endoscopic Resection of Gastric Subepithelial Tumors.

Chen H, Li B, Li L, Vachaparambil CT, Lamm V, Chu Y, Xu M, Cai Q. Chen H, et al. Among authors: xu m. Am J Gastroenterol. 2019 May;114(5):718-725. doi: 10.14309/ajg.0000000000000196. Am J Gastroenterol. 2019. PMID: 31082838 Review.

9

Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expression in esophageal squamous cell carcinoma.

Li ZX, Sun MC, Fang K, Zhao ZY, Leng ZY, Zhang ZH, Xu AP, Chu Y, Zhang L, Lian J, Chen T, Xu MD. Li ZX, et al. Cancer Biol Ther. 2023 Dec 31;24(1):2246206. doi: 10.1080/15384047.2023.2246206. Cancer Biol Ther. 2023. PMID: 37607071 Free PMC article.

10

Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.

Feng A, He L, Jiang J, Chu Y, Zhang Z, Fang K, Wang Z, Li Z, Sun M, Zhao Z, Shi J, Zhang L, Chen T, Xu M. Feng A, et al. Among authors: xu m. Cancer Sci. 2023 Aug;114(8):3270-3286. doi: 10.1111/cas.15842. Epub 2023 May 29. Cancer Sci. 2023. PMID: 37248653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

184 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year